PMC:5400020 / 22124-22421 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/5400020","sourcedb":"PMC","sourceid":"5400020","source_url":"https://www.ncbi.nlm.nih.gov/pmc/5400020","text":"The SAVI-registries have shown that transapical implantation using the ACURATE TATM device is safe and effective in an all-comers setting with low mortality, pacemaker and PVL rates, and stable haemodynamics throughout follow-up. There was no relevant difference in outcomes between SAVI-1 and -2.","tracks":[]}